News
10-31-2011, 07:33 AM
Circadian Technologies Limited announces that its 100% owned subsidiary, Vegenics Pty Ltd, has received approval for its investigational new drug application from the U.S. Food and Drug Administration to initiate clinical trials of VGX-100.
More... (http://www.news-medical.net/news/20111031/Vegenics-receives-IND-approval-from-FDA-for-VGX-100-Phase-I-study-in-late-stage-cancers.aspx)
More... (http://www.news-medical.net/news/20111031/Vegenics-receives-IND-approval-from-FDA-for-VGX-100-Phase-I-study-in-late-stage-cancers.aspx)